Associate Director, Global Commercial Portfolio Business Intelligence & Reporting Solutions at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

BA/BS required
MBA or Masters in a quantitative major or concentration preferred
5+ years of experience developing and using advanced analytics tools and platforms

Responsibilities

Ensures appropriate service delivery to Executives and Worldwide Brand Team as defined by stakeholder needs and Performance Management leadership direction
Facilitate business performance review meetings and related analytics requests
Centralizes and streamlines executive ad-hoc queries and Performance Management requests
Analyzes output of Performance Management services against stakeholder needs to ensure identified needs are addressed appropriately
Performs QA/QC for all executive Performance Management deliverables and is responsible for issue escalation to Performance Management leadership where appropriate
Works closely with other capability leads to identify unmet reporting needs
Leads development and deployment of scorecards supporting International Markets leadership to provide top-level understanding of key brand performance across all geographies
Serves as the connective layer between Headquarters and local performance discussions
Works closely with the in-market BI&A teams worldwide to design and operationalize consistent reporting capabilities in each country
Governs a consistent user experience across all global Performance Management services and tools
Defines process for developing standard cross-function metrics and templates for all Performance Management services while enabling customizability and flexibility
Defines Home Office reporting resourcing plan requirements based on Home Office requirements
Sustains governance of Business Performance processes for Commercial in partnership with cross-functional matrix team
Partners with technology and operations leadership to further develop Performance Management capabilities
Collaborates with Commercial, Analytics and IT partners to define the overall global data scope
Partners with international markets to streamline data process, enable an effective and efficient data environment and process
Identifies data gaps or overlaps to inform global data acquisition plans
Identifies the capability gaps in different markets/therapeutic areas
Works with function area experts to develop the capability framework and deployment plan
Drives the capability enablement process across markets/TA
Enables the latest AI technology
Leads the commercial performance workstream for upcoming brand/indication launches readiness to ensure launch success

Skills

Business Intelligence

Reporting

Analytics

Performance Management

Stakeholder Management

Data Analysis

QA/QC

Executive Reporting

Ad-hoc Queries

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free